Results 101 to 110 of about 97,726 (142)

Antibody-Negative Nivolumab-Induced Autoimmune Encephalitis: A Case Report and Review of Seronegative Presentations. [PDF]

Cureus
Hamza M, Randolph H, Thebault S.
europepmc   +1 more source

Hospital-mandated restrictions during the COVID-19 pandemic alter hospital-acquired viral respiratory infections during hematopoietic stem cell transplantation: a single center pediatric experience. [PDF]

Antimicrob Steward Healthc Epidemiol
Morocco P, Kumar M, Foote M, Cohen C, Nassin M, Cunningham J, LaBelle J.   +6 more
europepmc   +1 more source

Ethical and Clinical Considerations in the Workup of HIV-Associated Neurocognitive Decline. [PDF]

Cureus
Davis K, Grant KG, Sousou JM, Ilechukwu S.   +3 more
europepmc   +1 more source

The Neuroinfectious diseases profile in a specialist neurology centre in South Africa. [PDF]

eNeurologicalSci
Oosthuizen K, Marais S.
europepmc   +1 more source

Predictors of Radiological and Clinical Disease Reactivation in Multiple Sclerosis Patients After Cessation of Natalizumab (Tysabri). [PDF]

Brain Behav
Zibaoui RE, Ayoubi NKE, Khoury SJ.
europepmc   +1 more source

Erratum: Error in the Results.

JAMA Neurol
europepmc   +1 more source

Errors in the Results.

JAMA Neurol
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Amino Acid Uptake, Glucose Metabolism, and Neuroinflammation in John Cunningham Virus Associated Progressive Multifocal Leukoencephalopathy.

Clinical Nuclear Medicine, 2022
A 69-year-old woman presented with progressive dysarthria and cognitive deficits. On MRI, a T2-hyperintense, non-contrast-enhancing lesion was found in the left precentral area.
M. Unterrainer, Christoph Mahler, Adrian-Minh Schumacher, V. Ruf, B. Blum, S. Quach, M. Brendel, R. Rupprecht, P. Bartenstein, M. Kerschensteiner, T. Kümpfel, N. Albert   +11 more
semanticscholar   +3 more sources

Distribution and Quantity of Sites of John Cunningham Virus Persistence in Immunologically Healthy Patients: Correlation With John Cunningham Virus Antibody and Urine John Cunningham Virus DNA

JAMA Neurology, 2017
Although seroepidemiological studies indicate that greater than 50% of the population has been infected with John Cunningham virus (JCV), the sites of JCV persistence remain incompletely characterized.To determine sites of JCV persistence in immunologically healthy individuals.Tissue specimens from multiple sites including brain, renal, and nonrenal ...
J. Berger, Craig S. Miller, R. Danaher, Kathryn Doyle, K. Simon, E. Norton, L. Gorelik, E. Cahir-McFarland, D. Singhal, Nawaz Hack, J. R. Owens, P. Nelson, J. Neltner   +12 more
semanticscholar   +3 more sources